BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23893523)

  • 1. TNF-α in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab.
    Ferrero E; Belloni D; Corti A; Doglioni C; Dagna L; Ferrarini M
    Rheumatology (Oxford); 2014 Jan; 53(1):198-200. PubMed ID: 23893523
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximab.
    Dagna L; Corti A; Langheim S; Guglielmi B; De Cobelli F; Doglioni C; Fragasso G; Sabbadini MG; Ferrarini M
    J Clin Oncol; 2012 Oct; 30(28):e286-90. PubMed ID: 22869874
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recurrent pericardial effusion as first manifestation of Erdheim-Chester disease].
    Lutz SZ; Schmalzing M; Vogel-Claussen J; Adam P; May AE
    Dtsch Med Wochenschr; 2011 Sep; 136(39):1952-6. PubMed ID: 21935854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual Case of Recurrent Pericardial Effusion - Erdheim-Chester Disease.
    Jang JH; Oh J; Shim HS; Kang SM
    Circ J; 2019 Jul; 83(8):1762. PubMed ID: 30726803
    [No Abstract]   [Full Text] [Related]  

  • 5. Incessant pericardial effusion in a 9 year old male responding to infliximab.
    Walsh RF; Chowdhury D
    Cardiol Young; 2009 Aug; 19(4):413-5. PubMed ID: 19563688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmasked diabetes insipidus after pericardial drainage and biopsy for pericardial effusion in association with Erdheim-Chester disease.
    Augoustides JG; Szeto WY
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):217-8. PubMed ID: 18603080
    [No Abstract]   [Full Text] [Related]  

  • 7. Multimodality imaging showing complete cardiovascular involvement by Erdheim-Chester disease.
    Alharthi MS; Calleja A; Panse P; Appleton C; Jaroszewski DE; Tazelaar HD; Mookadam F
    Eur J Echocardiogr; 2010 Aug; 11(7):E25. PubMed ID: 20406735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erdheim-Chester disease presenting with large pericardial effusion: a mimic of disseminated malignancy.
    Jain P; Jepson N; Lawford R
    Intern Med J; 2011 Mar; 41(3):291-3. PubMed ID: 21426470
    [No Abstract]   [Full Text] [Related]  

  • 9. Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.
    Tomelleri A; Cavalli G; De Luca G; Campochiaro C; D'Aliberti T; Tresoldi M; Dagna L
    Front Immunol; 2018; 9():1233. PubMed ID: 29910817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent pericardial effusion and tamponade in a patient with Erdheim-Chester disease (ECD).
    Mishra AK; Mani S; George AA; Sudarsanam TD
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26604233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erdheim-Chester Disease: An Unusual Etiology of Recurrent Massive Pericardial Effusion.
    Lin J; Tang SQ; Chen JC; Zhang YH; Zhang Q
    Can J Cardiol; 2020 Nov; 36(11):1832.e11-1832.e13. PubMed ID: 32437730
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of multisystem Erdheim-Chester disease with pericardial effusion as the first symptom: Imaging findings.
    Lyu J; Xu Z; Qu X
    Asian J Surg; 2023 May; 46(5):2118-2120. PubMed ID: 36411169
    [No Abstract]   [Full Text] [Related]  

  • 13. Pericardial effusions on anti-TNF therapy for rheumatoid arthritis--a drug side effect or uncontrolled systemic disease?
    Edwards MH; Leak AM
    Rheumatology (Oxford); 2009 Mar; 48(3):316-7. PubMed ID: 19106166
    [No Abstract]   [Full Text] [Related]  

  • 14. Pericardial effusions with tamponade and visceral constriction in patients with rheumatoid arthritis on tumour necrosis factor (TNF)-inhibitor therapy.
    Soh MC; Hart HH; Corkill M
    Int J Rheum Dis; 2009 Apr; 12(1):74-7. PubMed ID: 20374322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericardial effusion as a crucial presentation of Erdheim-Chester disease in a hemodialysis patient: an overlooked diagnosis.
    Chen MT; Wang SM; Lin SY; Ting IW; Liu JH; Kuo HL; Huang CC
    Clin Nephrol; 2012 Jul; 78(1):81-4. PubMed ID: 22732342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful response to infliximab of recurrent pericardial graft versus host disease in a pediatric patient.
    Rubio PM; Labrandero C; Riesco S; Plaza D; González B; Muñoz GM; Sastre A
    Bone Marrow Transplant; 2013 Jan; 48(1):144-5. PubMed ID: 22580769
    [No Abstract]   [Full Text] [Related]  

  • 17. Multisystem Erdheim-Chester Disease With Extensive Pericardial and Vascular Involvement.
    Sánchez-Nadales A; Wang TKM; Anampa-Guzmán A; Xu B
    Circ Cardiovasc Imaging; 2020 Apr; 13(4):e010123. PubMed ID: 32208733
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-response to infliximab may be due to innate neutralizing anti-tumour necrosis factor-alpha antibodies.
    Ebert EC; Das KM; Mehta V; Rezac C
    Clin Exp Immunol; 2008 Dec; 154(3):325-31. PubMed ID: 18826498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of infliximab in the treatment of corticosteroid dependent collagenous colitis.
    Pola S; Fahmy M; Evans E; Tipps A; Sandborn WJ
    Am J Gastroenterol; 2013 May; 108(5):857-8. PubMed ID: 23644970
    [No Abstract]   [Full Text] [Related]  

  • 20. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.